Highlights HK inno.N Corporation

Equities

A195940

KR7195940002

End-of-day quote Korea S.E. Other stock markets 23:00:00 20/05/2024 BST			5-day change	1st Jan Change
38,050 ^KRW	-1.42%		-0.52%	-14.40%

2022	Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights from HK inno.N Corporation to Develop and Commercialize Tegoprazan in the U.S. and Canada	CI
2022	Sebela Pharmaceuticals Enters an Exclusive Partnership with HK inno.N Corporation	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights from HK inno.N Corporation to Develop and Commercialize Tegoprazan in the U.S. and Canada	28/10/22	CI
Sebela Pharmaceuticals Enters an Exclusive Partnership with HK inno.N Corporation	19/10/22	CI
Tranche Update on HK inno.N Corporation's Equity Buyback Plan announced on February 9, 2022.	09/08/22	CI
Tranche Update on HK inno.N Corporation's Equity Buyback Plan announced on February 9, 2022.	09/08/22	CI
HK inno.N Corporation's Equity Buyback announced on February 9, 2022, has expired with 574,608 shares, representing 1.99% for KRW 24,180.98 million.	08/08/22	CI
Tranche Update on HK inno.N Corporation's Equity Buyback Plan announced on February 9, 2022.	11/05/22	CI
Dr. Reddy's to Market HK inno.N's Gastrointestinal Diseases Drug in India, Emerging Markets	11/05/22	MT
Dr. Reddy's Laboratories Ltd. Enters into an Exclusive Partnership with South Korea-Based HK Inno.N Corporation	11/05/22	CI
HK inno.N's Gastroesophageal Reflux Disease Drug Gets Marketing Approval in China	18/04/22	MT
HK inno.N Corporation announces an Equity Buyback for KRW 24,200 million worth of its shares.	09/02/22	CI
HK inno.N Corporation authorizes a Buyback Plan.	08/02/22	CI
Kolmar Korea to Acquire 40% Stake in Biotech Firm Next & Bio	30/12/21	MT
South Korea's Secondary Stock Market Adds Largest Number of New Tech IPOs in 2021	28/12/21	MT
HK inno.N Corporation has completed an IPO in the amount of KRW 596.903 billion.	03/08/21	CI
HK inno.N Corporation has filed an IPO.	04/05/21	CI
Raqualia Pharma Inc. Announces an Expansion of the Strategic Alliance with CJ Healthcare Corp	29/11/19	CI
CKM Co., Ltd. completed the acquisition of CJ HealthCare Corp from CJ Cheiljedang Corporation.	17/04/18	CI
CKM Co., Ltd. signed an agreement to acquire CJ HealthCare Corp from CJ Cheiljedang Corporation for KRW 1.3 trillion.	19/02/18	CI
CJ Cheiljedang Seeks To Sell CJ Healthcare	05/11/17	CI
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Announces Agreement with CJ HealthCare on its CJ-12420 in Development and Commercialization for Acid-Related Diseases	22/10/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights HK inno.N Corporation

Equities

A195940

KR7195940002

Highlights

Filters